Press release
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancements In The Anti-Parkinson Drugs Market
Anti-Parkinson Drugs Market
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in 2025, reflecting a CAGR of 6.9%. This expansion in the past can be linked to an aging population, rising disease occurrence, improved healthcare systems, and progress in scientific research.
The anti-parkinson drugs market size is expected to experience strong growth in the next few years. It will increase to $13.73 billion by 2029 at a compound annual growth rate (CAGR) of 5.5%. Growth is driven by increased awareness, biotechnological advancements, and the expansion of emerging markets. Key trends include investment in R&D, personalized medicine, disease-modifying therapies, drug repurposing, telemedicine, remote monitoring, biosimilars, and research collaborations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3462
What Are the High-Growth Segments in the Anti-Parkinson Drugs Market?
The anti-parkinson drugs market covered in this report is segmented -
1) By Drugs Class: Levodopa Or Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs
2) By Route of Administration: Oral, Injection, Transdermal
3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies
Subsegments:
1) By Levodopa Or Carbidopa: Immediate-Release Levodopa Or Carbidopa, Extended-Release Levodopa Or Carbidopa
2) By Dopamine Receptor Agonists: Pramipexole, Ropinirole, Rotigotine
3) By Monoamine Oxidase Type B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide
4) By Catechol-O-Methyltransferase (COMT)-Inhibitors: Entacapone, Tolcapone
5) By Anticholinergics: Benztropine, Trihexyphenidyl
6) By Other Drugs: Amantadine, Apomorphine
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp
What Key Drivers Are Expected to Influence Future Anti-Parkinson Drugs Market Growth?
The rise in the elderly population and increased cases of Parkinson's disease are expected to elevate demand in the anti-Parkinson drugs market. Parkinson's is more prevalent in individuals over 60 years old. For example, the WHO stated in October 2022 that by 2030, one in six people globally will be aged 60 or older, with the number doubling to 2.1 billion by 2050. This demographic shift supports ongoing market growth.
Which Companies Hold the Largest Share Across Different Anti-Parkinson Drugs Market Segments?
Major companies operating in the anti-parkinson drugs market include GlaxoSmithKline plc, Pfizer Inc., Merck Co., Novartis AG, F. Hoffmann-La Roche AG, UCB S.A, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Mylan NV, C.H. Boehringer Sohn AG & Co. KG, Orion Pharma Ltd., ACADIA Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., US WorldMeds LLC, Zydus Lifesciences Limited, Chemical Industrial & Pharmaceutical Laboratories Ltd., Strides Shasun Ltd., Axcan Pharma Inc., Upsher-Smith Laboratories LLC, H. Lundbeck A/S, Vertical Pharmaceuticals LLC, Zambon SPA, M Somerset Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc.
What Trends Are Driving Growth in The Anti-Parkinson Drugs Market?
Companies in the anti-Parkinson drugs market are focusing on creating advanced therapies that address motor fluctuations and dyskinesia, common symptoms of Parkinson's disease. For example, AbbVie Inc. launched PRODUODOPA in January 2024, a 24-hour subcutaneous infusion therapy that aims to manage severe motor fluctuations and improve symptom control for patients with advanced Parkinson's disease.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report
What Are the Emerging Geographies for The Anti-Parkinson Drugs Market Growth?
North America was the largest region in the anti-Parkinson drugs market in 2023. Middle East is expected to be the fastest-growing region in the anti-parkinson drugs market during the forecast period. The regions covered in the anti-parkinson drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anti-Parkinson Drugs Market?
2. What is the CAGR expected in the Anti-Parkinson Drugs Market?
3. What Are the Key Innovations Transforming the Anti-Parkinson Drugs Industry?
4. Which Region Is Leading the Anti-Parkinson Drugs Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancements In The Anti-Parkinson Drugs Market here
News-ID: 4050252 • Views: …
More Releases from The Business Research Company
Global Double-Sided Masking Tapes Market Expansion at 7.8% CAGR, Valued at $18.4 …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Double-Sided Masking Tapes Market Size Forecast for 2025?
The market size of double-sided masking tapes has been experiencing consistent growth in recent years. The market will increase from a figure of $13.01 billion in 2024 to about $13.64 billion in 2025, demonstrating a compound annual growth rate…
Construction Adhesives Market on Path to Hit $18.32 Billion by 2029 at 9% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Construction Adhesives Market Outlook: What Size And CAGR Are Anticipated By 2025?
There has been a robust growth in the size of the construction adhesives market in the recent past. The market that was at $12.06 billion in 2024 is projected to rise to $12.95 billion in 2025, with a…
Future of Chromatography Resins Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Chromatography Resins Market by 2025?
In recent years, the market size of chromatography resins has experienced significant growth. Starting from a value of $2.95 billion in 2024, it is predicted to increase to $3.15 billion in 2025 with a compound annual growth…
Blow-Molded Plastics Industry Set to Achieve $128.73 Billion Milestone by 2029 | …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Blow-Molded Plastics Market Size 2025?
The market size of blow-molded plastics has seen constant enlargement in the previous few years. It is expected to rise from $97.17 billion in 2024 to $99.31 billion in 2025, at a compound annual growth rate (CAGR) of…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
